Loading...
XJPX
2934
Market cap47mUSD
Jul 10, Last price  
1,640.00JPY
1D
-2.03%
1Q
4.93%
IPO
-59.20%
Name

J Frontier Co Ltd

Chart & Performance

D1W1MN
XJPX:2934 chart
P/E
87.87
P/S
0.36
EPS
18.66
Div Yield, %
Shrs. gr., 5y
2.10%
Rev. gr., 5y
24.79%
Revenues
21.50b
+21.39%
6,125,810,0007,106,147,0008,493,011,00011,876,681,00016,844,572,00017,714,904,00021,504,496,000
Net income
88m
P
6,129,00096,373,000424,929,000400,519,000-1,899,918,000-2,086,426,00087,570,000
CFO
509m
P
13,993,000218,298,000830,912,000-366,943,000-1,830,377,000-1,435,744,000509,015,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

J Frontier Co.,Ltd. engages in the healthcare sales, medical care sales, and healthcare marketing businesses in Japan. The company operates SOKUYAKU, a platform for online medical treatment, online medication guidance, home delivery of prescription drugs, and digital transformation support for medical institutions. The company also sells health foods, health, beauty, education, healing, medicine, and medical care products through mail order; and provides product sales promotion support services. In addition, it offers Internet advertising for medical institutions and healthcare-related companies; and web marketing, in-store and TV shopping distribution, BPO support for logistics, etc. J Frontier Co.,Ltd. was incorporated in 2008 and is based in Shibuya, Japan.
IPO date
Aug 27, 2021
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑052024‑052023‑052022‑052021‑052020‑052019‑05
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT